Skeletal Radiology

, 36:24 | Cite as

PET-positive fibrous dysplasia - a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery

  • Klaus Strobel
  • Beata Bode
  • Didier Lardinois
  • Ulrich Exner
Case Report

Abstract

Benign bone tumors can show an increased FDG uptake in FDG-PET/CT investigations. In the presented case, an incidentally detected PET-positive asymptomatic fibrous dysplasia was initially misinterpreted as a metastasis in a patient with intimal sarcoma of the pulmonary artery.

Keywords

PET/CT Fibrous dysplasia Sarcoma 

References

  1. 1.
    Fitzpatrick KA, Taljanovic MS, Speer DP, et al. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR Am J Roentgenol 2004;182:1389–1398PubMedGoogle Scholar
  2. 2.
    Kransdorf MJ, Moser RP Jr, Gilkey FW. Fibrous dysplasia. Radiographics 1990;10:519–537PubMedGoogle Scholar
  3. 3.
    Sathekge MM, Clauss RP. Criteria and quantification of fibrous dysplasia on MDP scanning. Nuklearmedizin 1995;34:229–231PubMedGoogle Scholar
  4. 4.
    Parekh SG, Donthineni-Rao R, Ricchetti E, Lackman RD. Fibrous dysplasia. J Am Acad Orthop Surg 2004;12:305–313PubMedGoogle Scholar
  5. 5.
    Macapinlac HA. FDG PET and PET/CT imaging in lymphoma and melanoma. Cancer J 2004;10:262–270PubMedGoogle Scholar
  6. 6.
    Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500–2507CrossRefPubMedGoogle Scholar
  7. 7.
    Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191–196CrossRefPubMedGoogle Scholar
  8. 8.
    Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27:822–832CrossRefPubMedGoogle Scholar
  9. 9.
    Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (“USA-Fat”): description on 18F-FDG PET/CT. J Nucl Med 2003;44:170–176PubMedGoogle Scholar
  10. 10.
    Zhuang H, Sam JW, Chacko TK, et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging 2003;30:1096–1103CrossRefPubMedGoogle Scholar
  11. 11.
    Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 2004;45:266–271PubMedGoogle Scholar
  12. 12.
    Lardinois D, Weder W, Roudas M, et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 2005;23:6846–6853CrossRefPubMedGoogle Scholar
  13. 13.
    Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001;219:774–777PubMedGoogle Scholar
  14. 14.
    Shigesawa T, Sugawara Y, Shinohara I, Fujii T, Mochizuki T, Morishige I. Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia. Clin Nucl Med 2005;30:571–573CrossRefPubMedGoogle Scholar
  15. 15.
    Toba M, Hayashida K, Imakita S, et al. Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia. Ann Nucl Med 1998;12:153–155PubMedCrossRefGoogle Scholar
  16. 16.
    Huvos AG, Higinbotham NL, Miller TR. Bone sarcomas arising in fibrous dysplasia. J Bone Joint Surg Am 1972;54:1047–1056PubMedGoogle Scholar
  17. 17.
    Harris WH, Dudley HR Jr, Barry RJ. The natural history of fibrous dysplasia. An orthopaedic, pathological, and roentgenographic study. J Bone Joint Surg Am 1962;44:207–233PubMedGoogle Scholar
  18. 18.
    Present D, Bertoni F, Enneking WF. Osteosarcoma of the mandible arising in fibrous dysplasia. A case report. Clin Orthop 1986;204:238–244PubMedGoogle Scholar
  19. 19.
    Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000;6:1279–1287PubMedGoogle Scholar
  20. 20.
    Eary JF, Conrad EU, Bruckner JD, et al. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998;4:1215–1220PubMedGoogle Scholar
  21. 21.
    Fayad LM, Cohade C, Wahl RL, Fishman EK. Sacral fractures: a potential pitfall of FDG positron emission tomography. AJR Am J Roentgenol 2003;181:1239–1243PubMedGoogle Scholar
  22. 22.
    Shon IH, Fogelman I. F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 2003;28:171–175CrossRefPubMedGoogle Scholar
  23. 23.
    Tsuyuguchi N, Ohata K, Morino M, et al. Magnetic resonance imaging and [11C]methyl-L-methionine positron emission tomography of fibrous dysplasia-two case reports. Neurol Med Chir (Tokyo) 2002;42:341–345CrossRefGoogle Scholar
  24. 24.
    Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993;186:45–53PubMedGoogle Scholar
  25. 25.
    Schirrmeister H, Guhlmann A, Elsner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med 1999;40:1623–1629PubMedGoogle Scholar
  26. 26.
    Hetzel M, Arslandemir C, Konig HH, et al. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res 2003;18:2206–2214PubMedCrossRefGoogle Scholar
  27. 27.
    Langsteger W, Heinisch M, Fogelman I. The Role of Fluorodeoxyglucose, (18)F-Dihydroxyphenylalanine, (18)F-Choline, and (18)F-Fluoride in Bone Imaging with Emphasis on Prostate and Breast. Semin Nucl Med 2006;36:73–92CrossRefPubMedGoogle Scholar

Copyright information

© ISS 2006

Authors and Affiliations

  • Klaus Strobel
    • 1
  • Beata Bode
    • 2
  • Didier Lardinois
    • 3
  • Ulrich Exner
    • 4
  1. 1.Division of Nuclear Medicine, Department of Medical RadiologyUniversity HospitalZurichSwitzerland
  2. 2.Institute of Surgical PathologyUniversity HospitalZurichSwitzerland
  3. 3.Department of Thoracic SurgeryUniversity HospitalZurichSwitzerland
  4. 4.Department of Orthopaedic Tumor SurgeryOrthopedic University Hospital BalgristZurichSwitzerland

Personalised recommendations